Detalhe da pesquisa
1.
CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells.
Proc Natl Acad Sci U S A
; 116(52): 26846-26852, 2019 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818947
2.
Engineering human skin model innervated with itch sensory neuron-like cells differentiated from induced pluripotent stem cells.
Bioeng Transl Med
; 7(1): e10247, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111948
3.
Targeting the Jak/Signal Transducer and Activator of Transcription 3 Pathway with Ruxolitinib in a Mouse Model of Recessive Dystrophic Epidermolysis Bullosa-Squamous Cell Carcinoma.
J Invest Dermatol
; 141(4): 942-946, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33069729